Phenylephrine HCl

製品コードS2569 バッチS256901

印刷

化学情報

 Chemical Structure Synonyms NCI-C55641 HCl,(R)-(-)-Phenylephrine hydrochloride, L-Phenylephrine hydrochloride Storage
(From the date of receipt)
3 years -20°C powder
1 years -80°C in solvent
化学式

C9H13NO2.HCl

分子量 203.67 CAS No. 61-76-7
Solubility (25°C)* 体外 DMSO 41 mg/mL (201.3 mM)
Water 41 mg/mL (201.3 mM)
Ethanol 41 mg/mL (201.3 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液(一定の濃度)を調合する

生物活性

製品説明 Phenylephrine HCl is a selective α1-adrenergic receptor agonist, used primarily as a decongestant.
in vitro

Phenylephrine causes a rapid translocation of PKC-epsilon (EC50 = 0.9 mM) but the proportion lost from the soluble fraction is less than with ET-1. [1] Phenylephrine at pCa 7 causes a dose-dependent increase in contractile force of the hyperpermeable cells, which is reversible on addition of phentolamine. [2] Phenylephrine also protects cardiomyocytes against subsequent 24 h treatment with hypoxia and serum deprivation. Phenylephrine prevents the down-regulation of Bcl-2 and Bcl-X mRNA/protein and induces hypertrophic growth. Phenylephrine-mediated protection is abrogated by the phosphatidylinositol 3-kinase (PI 3-kinase) inhibitor wortmannin and is mimicked by the caspase-9 peptidic inhibitor LEHD-fmk. [3] Phenylephrine stimulates phosphoinositide (PI) hydrolysis, cell growth, and expression of several genes [e.g., atrial natriuretic factor (ANF)] often associated with cardiac hypertrophy. [4] Phenylephrine (1 礛) markedly potentiates HGF-induced hepatocyte DNA synthesis and proliferation. [5] Phenylephrine (10 mM) reversibly increases I(Ca,L) (51.3%; n = 40) and shifted peak I(Ca,L) activation voltage by -10 mV. Phenylephrine also increases local, subsarcolemmal SR Ca2+ release via IP3-dependent signaling. Phenylephrin-induced NOi release requires stimulation of both PI-3K/Akt and IP3-dependent Ca2+ signaling. Phenylephrine-induced NOi release is inhibited by each of 1 mM prazocin, 10 mM L-NIO, 10 mM W-7, 10 mM LY294002, 2 mM H-89, 10 mM ryanodine, 5 mM thapsigargin, 2 mM 2-APB or 10 mM xestospongin C. [6]

プロトコル(参考用のみ)

カスタマーフィードバック

Data from [Data independently produced by , , Stem Cells Dev, 2017, 26(7):528-540]

Selleckの高級品が、幾つかの出版された研究調査結果(以下を含む)で使われた:

A modified apical resection model with high accuracy and reproducibility in neonatal mouse and rat hearts [ NPJ Regen Med, 2023, 8(1):9] PubMed: 36806296
α1-adrenoceptor stimulation ameliorates lipopolysaccharide-induced lung injury by inhibiting alveolar macrophage inflammatory responses through NF-κB and ERK1/2 pathway in ARDS [ Front Immunol, 2022, 13:1090773] PubMed: 36685596
α1-adrenoceptor stimulation ameliorates lipopolysaccharide-induced lung injury by inhibiting alveolar macrophage inflammatory responses through NF-κB and ERK1/2 pathway in ARDS [ Front Immunol, 2022, 10.3389/fimmu.2022.1090773] PubMed: 36685596
Rap1GAP Mediates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Inhibiting Autophagy and Increasing Oxidative Stress [ Oxid Med Cell Longev, 2021, 2021:7848027] PubMed: 33936386
A CRM1 Inhibitor Alleviates Cardiac Hypertrophy and Increases the Nuclear Distribution of NT-PGC-1α in NRVMs [ Front Pharmacol, 2019, 10:465] PubMed: 31133853
17β-Estradiol nongenomically induces vascular endothelial H2S release by promoting phosphorylation of cystathionine γ-lyase [ J Biol Chem, 2019, 294(43):15577-15592] PubMed: 31439665
The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation. [ Sci Adv, 2019, 5(5):eaau0495] PubMed: 31086810
N‑terminal truncated peroxisome proliferator‑activated receptor‑γ coactivator‑1α alleviates phenylephrine‑induced mitochondrial dysfunction and decreases lipid droplet accumulation in neonatal rat cardiomyocytes. [ Mol Med Rep, 2018, 18(2):2142-2152] PubMed: 29901150
Efficient Differentiation of TBX18+/WT1+ Epicardial-Like Cells from Human Pluripotent Stem Cells Using Small Molecular Compounds. [Zhao J, et al. Stem Cells Dev, 2017, 26(7):528-540] PubMed: 27927069

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。